SEC Form D private-offering filing

Amphix Bio, Inc.

Name: Amphix Bio, Inc. - new SEC Form D private-offering filing, Chicago, IL
Published: 2025-12-19

A new SEC Form D private-offering notice from Chicago, IL, a $12,500,000 filer-stated offering target in Biotech. The source filing is one click away.

Amphix Bio, Inc. site↗ Verified via SEC Form D

Preclinical biotech developing supramolecular peptide therapeutics for neurological injuries and neurodegenerative diseases, spun out of Northwestern University.

Filed 2025-12-19Filed to raise $12,500,000First money in 2025-12-04Raised so far $10,300,000HQ (as filed) Chicago, ILSector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified amphixbio.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in Illinois →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.